Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats.

The increased breast cancer risk in female night shift workers has been postulated to result from the suppression of pineal melatonin production by exposure to light at night. Exposure of rats bearing rat hepatomas or human breast cancer xenografts to increasing intensities of white fluorescent light during each 12-hour dark phase (0-345 microW/cm2) resulted in a dose-dependent suppression of nocturnal melatonin blood levels and a stimulation of tumor growth and linoleic acid uptake/metabolism to the mitogenic molecule 13-hydroxyoctadecadienoic acid. Venous blood samples were collected from healthy, premenopausal female volunteers during either the daytime, nighttime, or nighttime following 90 minutes of ocular bright, white fluorescent light exposure at 580 microW/cm2 (i.e., 2,800 lx). Compared with tumors perfused with daytime-collected melatonin-deficient blood, human breast cancer xenografts and rat hepatomas perfused in situ, with nocturnal, physiologically melatonin-rich blood collected during the night, exhibited markedly suppressed proliferative activity and linoleic acid uptake/metabolism. Tumors perfused with melatonin-deficient blood collected following ocular exposure to light at night exhibited the daytime pattern of high tumor proliferative activity. These results are the first to show that the tumor growth response to exposure to light during darkness is intensity dependent and that the human nocturnal, circadian melatonin signal not only inhibits human breast cancer growth but that this effect is extinguished by short-term ocular exposure to bright, white light at night. These mechanistic studies are the first to provide a rational biological explanation for the increased breast cancer risk in female night shift workers.

[1]  K. Fox,et al.  Timing Is Everything , 2000, Neuron.

[2]  K. Welham,et al.  Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. , 2004, The Journal of nutrition.

[3]  C. A. Bernecker,et al.  Biological Effects of Architectural Lighting and Their Associated Energy Utilization , 1994 .

[4]  Vincent Laudet,et al.  The days and nights of cancer cells. , 2003, Cancer research.

[5]  R. Reiter,et al.  Pineal melatonin: cell biology of its synthesis and of its physiological interactions. , 1991, Endocrine reviews.

[6]  G. Brainard,et al.  The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian hamster: a dose-response relationship. , 1983, Endocrinology.

[7]  Josephine Arendt,et al.  Health in a 24-h society , 2001, The Lancet.

[8]  R. Stevens,et al.  Inverse association between breast cancer incidence and degree of visual impairment in Finland , 1999, British Journal of Cancer.

[9]  M. Dubocovich,et al.  Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. , 2001, American journal of physiology. Cell physiology.

[10]  Christian Bartsch,et al.  The Pineal Gland and Cancer , 2001, Springer Berlin Heidelberg.

[11]  Blask De,et al.  Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. , 1986 .

[12]  T. Eling,et al.  Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate , 2002, The Journal of Biological Chemistry.

[13]  N. Kerenyi,et al.  Why the incidence of cancer is increasing: the role of 'light pollution'. , 1990, Medical hypotheses.

[14]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[15]  G. Brainard,et al.  Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. , 1999, Cancer letters.

[16]  S. Reppert,et al.  Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.

[17]  D. Blask,et al.  Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. , 2004, Carcinogenesis.

[18]  S. Hill,et al.  Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. , 1986, Journal of neural transmission. Supplementum.

[19]  J. Boutin,et al.  New selective ligands of human cloned melatonin MT1 and MT2 receptors , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[21]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[22]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[23]  W. Glasgow,et al.  The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation , 1997, The Journal of Biological Chemistry.

[24]  H. Kraemer,et al.  Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.

[25]  J. Gusella,et al.  Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Reiter.  Pineal gland : interface between the photoperiodic environment and the endocrine system , 1991 .

[27]  L. Sauer,et al.  Identification of linoleic and arachidonic acids as the factors in hyperlipemic blood that increase [3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. , 1988, Cancer research.

[28]  U. Kelavkar,et al.  15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. , 2004, Neoplasia.

[29]  Francine Laden,et al.  Night-shift work and risk of colorectal cancer in the nurses' health study. , 2003, Journal of the National Cancer Institute.

[30]  T. Åkerstedt,et al.  Metabolic responses to nocturnal eating in men are affected by sources of dietary energy. , 2002, The Journal of nutrition.

[31]  Johnni Hansen,et al.  Increased Breast Cancer Risk among Women Who Work Predominantly at Night , 2001, Epidemiology.

[32]  A C Bird,et al.  Relationship between melatonin rhythms and visual loss in the blind. , 1997, The Journal of clinical endocrinology and metabolism.

[33]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.

[34]  G. Brainard,et al.  Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.

[35]  S. M. Pauley.  Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. , 2004, Medical hypotheses.

[36]  F Laden,et al.  Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. , 2001, Journal of the National Cancer Institute.

[37]  G. Brainard,et al.  The effect of different light intensities on pineal melatonin content , 1982, Brain Research.

[38]  David E. Blask,et al.  Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression , 2003, Breast Cancer Research and Treatment.

[39]  D. Blask,et al.  Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. , 2002, Current topics in medicinal chemistry.

[40]  S. Hampton,et al.  Circadian Aspects of Postprandial Metabolism , 2003, Chronobiology international.

[41]  G. Brainard,et al.  Photic Regulation of Melatonin in Humans: Ocular and Neural Signal Transduction , 1997, Journal of biological rhythms.

[42]  Tongzhang Zheng,et al.  Period3 structural variation: a circadian biomarker associated with breast cancer in young women. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  R. Cheney,et al.  Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. , 2002, American journal of clinical pathology.

[44]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[45]  D. Blask,et al.  Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. , 1999, Cancer research.

[46]  R. Stevens,et al.  Night shift work, light at night, and risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[47]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[48]  M. Lippman,et al.  ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER , 1978, The Lancet.

[49]  Jared Rutter,et al.  Metabolism and the control of circadian rhythms. , 2002, Annual review of biochemistry.

[50]  M. Dubocovich,et al.  Molecular pharmacology, regulation and function of mammalian melatonin receptors. , 2003, Frontiers in bioscience : a journal and virtual library.

[51]  W. Hrushesky.  Timing Is Everything , 1994 .

[52]  W. Hrushesky.  The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance. , 2000, Japanese journal of clinical oncology.

[53]  D. Blask,et al.  Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism. , 2001, Endocrinology.

[54]  W. Hrushesky.  Tumor chronobiology. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[55]  D. Blask,et al.  Oral melatonin supplementation in rats and a human subject suppresses the growth activity of steroid receptor negative human breast cancer xenografts in female nude rats via an MT1 receptor-mediated suppression of signal tranduction and linoleic acid uptake and metabolism , 2005 .

[56]  M. Shafii,et al.  Melatonin in psychiatric and neoplastic disorders , 1998 .

[57]  Prahlad T. Ram,et al.  Involvement of the mt1 melatonin receptor in human breast cancer. , 2002, Cancer letters.